Speed
79 days to first decision for reviewed manuscripts only
75 days to first decision for all manuscripts
120 days from submission to acceptance
19 days from acceptance to publication
Citation Impact
1.096 - Source Normalized Impact per Paper (SNIP)
0.477 - SCImago Journal Rank (SJR)
2.400 - CiteScore
Usage
101,345 Downloads
9 Altmetric Mentions
Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report
Acute macular neuroretinopathy (AMN) is a visual-deteriorating rare clinical entity with an uncertain etiology. We aimed to report a case of AMN and underlying disease of acute myeloid leukemia (AML).
Citation: Journal of Ophthalmic Inflammation and Infection 2021 10:39